Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

PVR reassessed as predictor of heart failure

Publish date:: August 7, 2020

Key clinical point: Pulmonary hypertension outcomes worsen with pulmonary vascular resistance > 2.2 Wood units.

Major finding: Adjusted hazard ratio was 1.09 for mortality at 2.2 Wood units.

Study details: Retrospective cohort study of 40,082 patients who had right heart catheterization in the VA health care system.

Disclosures: Dr. Maron disclosed financial relationships with Actelion.

Citation:

Maron BA et al. Lancet Respir Med. 2020 Jul 27: doi: 10.1016/S2213-2600(20)30317-9.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Cardiology

Sac/val heart failure benefit extends to diabetes patients,

Sedentary postmenopausal women have higher heart failure risk,

Experts disagree with USPSTF’s take on pediatric blood pressure screening,

GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit,

Don’t miss cardiovascular risk factors in transgender patients,